Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions” is a research paper published in Alzheimer s & Dementia Translational Research & Clinical Interventions (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01AG046170
National Institutes of Health
Grant: RF1AG058469
National Institutes of Health
Grant: RF1AG059319
National Institutes of Health
Grant: R01AG061894
National Institutes of Health
Grant: P30 AG066514
National Institutes of Health
Grant: 5R01AG061894-05
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
National Institutes of Health
Grant: 3U01AG046170-01S1
Accelerating Medicine Partnership in Alzheimer's Disease: Enabling collaborative
National Institutes of Health
Grant: 3P30AG066514-01S1
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1RF1AG058469-01A1
Integrated understanding of complex viral network biology in Alzheimer's Disease
National Institutes of Health
Grant: 1RF1AG059319-01
SYSTEMATIC DRUG REPURPOSING TARGETING IMMUNE ACTIVATION NETWORKS IN ALZHEIMER'S DISEASE (AD)
FWCI
0.14
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals